Joel Isaacson & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-928
Closed -$49K 509
2013
Q2
$49K Buy
+928
New +$49K 0.02% 227